Clinical Trial Update: Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE) [Phase 2, Phase 3]

View source ↗

Summary

The STEEPLE trial evaluated the safety and efficacy of enoxaparin in patients undergoing percutaneous coronary intervention, with Phase 2/3 results now complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Sanofi | Conditions: Percutaneous Coronary Intervention | Phase 2, Phase 3 | Status: COMPLETED